Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA Farhat Nasim8 Nov 2019 4:30 AM GMTErlotinib Tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug (RLD) TARCEVA used in the treatment of patients with meta...
Sun Pharma launches cancer drug INFUGEM in US market Farhat Nasim9 April 2019 4:35 AM GMTSun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied t...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 4:00 AM GMTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection US...
